Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Roche

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Ebiomedicine|December 11, 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapyJennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Annals of Neurology|July 26, 2023
Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIVThomas A Angelovich, Catherine R Cochrane, Jingling Zhou, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Nature Communications|July 1, 2026
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4<sup>+</sup> T cellsPaula M Cevaal, Abdalla Ali, Marcel Doerflinger, et al.
Annals of Neurology|July 22, 2022
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ARTCatherine R Cochrane, Thomas A Angelovich, Sarah J Byrnes, et al.
Retrovirology|April 23, 2013
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutationsMichael Roche, Hamid Salimi, Renee Duncan, et al.
Borderline Personality Disorder and Emotion Dysregulation|December 13, 2019
Borderline personality disorder diagnosis in a new keyAbby L Mulay, Mark H Waugh, J Parks Fillauer, et al.
The Journal of Biological Chemistry|April 3, 2016
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4Katherine Griffiths, Olan Dolezal, Benjamin Cao, et al.
Journal of Psychopathology and Clinical Science|December 26, 2023
Principles and procedures for revising the hierarchical taxonomy of psychopathologyMiriam K Forbes, Whitney R Ringwald, Timothy Allen, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Ebiomedicine|December 11, 2022
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapyJennifer M Zerbato, Anchalee Avihingsanon, Kasha P Singh, et al.
The Journal of Infectious Diseases|December 5, 2019
Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral TherapyJenny L Anderson, Gabriela Khoury, Rémi Fromentin, et al.
Annals of Neurology|July 26, 2023
Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIVThomas A Angelovich, Catherine R Cochrane, Jingling Zhou, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Nature Communications|July 1, 2026
Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4<sup>+</sup> T cellsPaula M Cevaal, Abdalla Ali, Marcel Doerflinger, et al.
Annals of Neurology|July 22, 2022
Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ARTCatherine R Cochrane, Thomas A Angelovich, Sarah J Byrnes, et al.
Retrovirology|April 23, 2013
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutationsMichael Roche, Hamid Salimi, Renee Duncan, et al.
Borderline Personality Disorder and Emotion Dysregulation|December 13, 2019
Borderline personality disorder diagnosis in a new keyAbby L Mulay, Mark H Waugh, J Parks Fillauer, et al.
The Journal of Biological Chemistry|April 3, 2016
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4Katherine Griffiths, Olan Dolezal, Benjamin Cao, et al.
Journal of Psychopathology and Clinical Science|December 26, 2023
Principles and procedures for revising the hierarchical taxonomy of psychopathologyMiriam K Forbes, Whitney R Ringwald, Timothy Allen, et al.
Pageof 15